Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Glaucoma > Study finds high risk of vision loss in juvenile open-angle glaucoma patients
  • Glaucoma

Study finds high risk of vision loss in juvenile open-angle glaucoma patients

Ophthalmology 360

Juvenile open-angle glaucoma (JOAG) often leads to severe and progressive vision loss despite treatment, and patients who undergo more glaucoma surgeries are at higher risk for worsening visual impairment, according to a study.

The retrospective study analyzed data from 106 patients (203 eyes) treated over 13 years at 2 tertiary hospitals, with a minimum follow-up of 1 year. World Health Organization criteria was used to assess visual outcomes at diagnosis and final follow-up.

At the outset, 31.5% of eyes were blind. After an average follow-up of nearly 8 years, that number rose to 35.5% of eyes. Bilateral blindness also increased from 15.2% to 19.8%. Among those with no vision loss at diagnosis, most maintained stable vision for up to 5 years. However, those with moderate impairment were more likely to progress.

Although progression rates did not differ significantly across visual categories, the study identified a higher number of glaucoma surgeries as a key risk factor for worsening vision (adjusted hazard ratio 2.25).

Reference
Seresirikachorn K, Vu DM, Narayana A, et al. Visual Outcomes and Risk Factors For Progression in Juvenile Open-Angle Glaucoma. Ophthalmol Glaucoma. 2025;S2589-4196(25)00113-9. doi: 10.1016/j.ogla.2025.06.003. Epub ahead of print. PMID: 40505968.

Share

Related Content

  • Glaucoma

Poor sleep quality linked to glaucoma severity in older adults

  • Glaucoma

Glaucoma drainage devices provide meaningful IOP control in pediatric glaucoma

  • Glaucoma

Expanding the glaucoma treatment landscape with FLIGHT technology

  • Glaucoma

Geographic differences in glaucoma care raise concerns about equitable access

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon